Press Releases
Links to our recent press releases can be accessed in PDF format using Acrobat Reader.
To receive Pervasis’ press releases by email, please sign up for Email & News Alerts.
2010
February 1, 2010
Pervasis Therapeutics Receives FDA Clearance for Pivotal Phase 3 Trial of Vascugel® [PDF]
2009
September 16, 2009
Pervasis Therapeutics Announces $17 Million in Financing and New Board Member [PDF]
May 19, 2009
Pervasis Therapeutics Presents Promising Preclinical Data for its Minimally Invasive Cell Therapy at the European Association of Percutaneous Cardiovascular Interventions Annual Congress (EuroPCR) [PDF]
May 12, 2009
Pervasis Therapeutics to Present Preclinical Data on Novel, Minimally Invasive Cellular Therapy at the European Association of Percutaneous Cardiovascular Interventions Annual Congress [PDF]
May 5, 2009
Pervasis Therapeutics Granted Orphan Drug Designation for Vascugel® [PDF]
2008
November 19, 2008
Pervasis Therapeutics Announces Promising Efficacy Results from Phase 1 and 2 Clinical Trials of Vascugel® in Dialysis Patients Needing Permanent AV Access, Data Builds on Compelling Safety Findings [PDF]
November 12, 2008
Pervasis Therapeutics to Present Safety and Efficacy Data from Phase 1 and 2 Clinical Trials of Vascugel® at the 35th Annual VEITHsymposium™ [PDF]
November 6, 2008
Pervasis Therapeutics Presents Safety Data from Phase 1 and 2 Clinical Trials of Vascugel® at the American Society of Nephrology Annual Meeting [PDF]
October 30, 2008
Pervasis Therapeutics to Present Data from Phase 1 and 2 Clinical Trials of Vascugel® at the American Society of Nephrology 41st Annual Meeting and Scientific Exposition [PDF]
October 21, 2008
Pervasis Therapeutics Appoints Life Sciences Industry Executive Frederic Chereau as Company's President and Chief Executive Officer [PDF]
October 17, 2008
Pervasis Therapeutics to Present at First Annual Boston Biotech R&D Conference [PDF]
August 5, 2008
Pervasis Therapeutics Appoints Frank Litvack, M.D., Former CEO of Conor Medsystems, to its Board of Directors [PDF]
January 15, 2008
Pervasis Therapeutics Closes Additional $9.75 Million in Financing [PDF]
2007
September 17, 2007
Pervasis Therapeutics announces New Animal Study Results Supporting Vascugel™ in Promoting Healing after Blood Vessel Injury [PDF]
August 13, 2007
Pervasis Therapeutics Successfully Completes Enrollment for Vascugel™ Phase II Clinical Trials [PDF]
May 15, 2007
Pervasis Therapeutics, Inc. Named to Red Herring 100, Spring 2007 [PDF]
April 17, 2007
Pervasis Therapeutics Selected as a Finalist for the Red Herring 100 North American 2007 [PDF]
March 19, 2007
Pervasis Therapeutics Launches Enrollment for Two Phase II Clinical Trials for Vascugel [PDF]
2006
November 15, 2006
Pervasis Therapeutics Announces Successful Initial Safety Results of Phase I Trials [PDF]
September 27, 2006
Pervasis Therapeutics' Vascugel Initiates U.S. Clinical Trials [PDF]
2005
September 30, 2005
Pervasis Therapeutics Closes 12 Million Series B Financing [PDF]
September 30, 2005
Pervasis Therapeutics Expands Team [PDF]